Evolution of Epitope Regions in Hiv Genome: Delineating Selective Forces Acting on Conformational and Linear Epitopes

Total Page:16

File Type:pdf, Size:1020Kb

Evolution of Epitope Regions in Hiv Genome: Delineating Selective Forces Acting on Conformational and Linear Epitopes EVOLUTION OF EPITOPE REGIONS IN HIV GENOME: DELINEATING SELECTIVE FORCES ACTING ON CONFORMATIONAL AND LINEAR EPITOPES A thesis submitted to Kent State University in partial fulfillment of the requirements for the degree of Master of Sciences By Satish Kumar Perikala May 2010 Thesis Written by Satish Kumar Perikala B.V.Sc & A.H, Acharya N.G Ranga Agricultural University, India 2004 M.S Kent State University, 2010 Approved by ___________________________________, Advisor Helen Piontkivska ___________________________________, Member, Masters Thesis Committee Gail Fraizer ___________________________________, Member, Masters Thesis Committee Michael Tubergen Accepted by ___________________________________, Chair, Department of Biomedical Sciences Robert V Dorman ___________________________________, Dean, College of Arts and Sciences John R.D. Stalvey ii TABLE OF CONTENTS LIST OF FIGURES.......................................................................................................v LIST OF TABLES........................................................................................................vii LIST OF ABBREVIATIONS………………………………………………………..ix ACKNOWLEDGEMENTS…………………………………………….…………….x CHAPTER 1: INTRODUCTION……………………………………………………………1 HIV Genome……………………………………………….…………..4 Geographical Distribution of HIV world wide…………….…………..5 Different Types of Immune Epitopes in HIV…………….……………6 Thesis Overview………………………………………….……………9 CHAPTER 2: MATERIALS AND METHODS……………………………………...……...13 HIV genomic sequence data and multiple sequence alignment……...14 HIV Epitopes………………………………………………………....15 Nucleotide Substitution Patterns………………………………….….15 Reconstruction of Ancestral Sequence……………………………….17 Radical and Conservative Amino acid Substitutions…………………18 Phylogenetic Analysis…………………………………………...……18 CHAPTER 3: Patterns of synonymous and nonsynonymous substitutions at different epitope regions among B-subtype and CRF subtype HIV-1 sequences……..30 Results………………………………………………………………….31 Discussion…………………………………………..……………….…35 CHAPTER 4: Patterns of radical and conservative amino acid changes at different epitope regions among selected B-subtype and CRF HIV-1 sequences……..43 iii Results………………………………………………………………..44 Discussion……………………………………………………………50 SUMMARY…………………………………………………………………………66 LITERATURE CITED………………………………………………………………81 APPENDIX 1. Box Plots showing the d S - d N values in different epitope regions of Env gene…………………………………………………………………………..68 2. Box Plots showing the d S - d N values in different epitope regions of Gag gene…………………………………………………………………………..70 3. Box Plots showing the d S - d N values in different epitope regions of Pol gene………………………………………………………………………..…71 4. List of CTL epitopes used…………………………...……………..…..….72 5. List of T-Helper epitopes used……………………...………………...…...76 6. List of Antibody epitopes used……………………………………….…...79 7. List of conformational epitopes used………………………………..….…80 iv LIST OF FIGURES Fig 1.1 Overview of the Life cycle of HIV (From: Sewell 2000)…………..………..11 Fig 1.2 Structure of HIV Genome (Modified from Los Alamos HIV database)… ….11 Fig 1.3 Global Distribution of HIV subtypes (From: International AIDS Vaccine Initiative) Report, 2003.………………… … ……………….……….……………...12 Fig 2.1 Example showing the Synonymous and Nonsynonymous Substitutions.........19 Fig 2.2 Phylogenetic tree showing the ancestral sequence of Env gene of B-subtype sequences……………………………………………………….…………………….19 Fig 2.3 Phylogenetic tree showing the ancestral sequence of Gag gene of B-subtype sequences……………………………………….………………………….…………20 Fig 2.4 Phylogenetic tree showing the ancestral sequence of Pol gene of B-Subtype sequences…………………………………………………………………..…………20 Fig 2.5 Phylogenetic tree showing the ancestral sequence of Env gene of CRF-subtype sequences……………………………………………………………………………21 Fig 2.6 Phylogenetic tree showing the ancestral sequence of Gag gene of CRF-subtypes sequences……………………………………………………………………………22 Fig 2.7 Phylogenetic tree showing the ancestral sequence of Pol gene of CRF-subtypes sequences……………………………………………………………………………23 Fig 3.1 Bar graph showing the mean d N and d S values of different epitope regions of Env gene for B and CRF sequences ………………………………………….…………..38 Fig 3.2 Bar graph showing the mean d N and d S values of different epitope regions of Gag gene for B and CRF sequences ………………………………………………...39 v Fig 3.3 Bar graph showing the mean d N and d S values of different epitope regions of Pol gene for B and CRF sequences…………………………………………….………40 Fig 4.1 Bar graph showing number of Radical and Conservative amino acid changes at different epitope regions of Env ,Gag and Pol genes from B and CRF sequences based on the classification of amino acids by Polarity…………………………..……..…54 Fig 4.2 Bar graph showing number of Radical and Conservative amino acid changes at different epitope regions of Env ,Gag and Pol genes from B and CRF sequences based on the classification of amino acids by Charge……………………………………55 Fig 4.3 Bar graph showing number of Radical and Conservative amino acid changes at different epitope regions of Env ,Gag and Pol genes from B and CRF sequences based on the classification of amino acids by Polarity AND Volume……………………56 Fig 4.4 Bar graphs showing the proportion of Radical changes relative to the total number of changes in Env gene……………………………………………………………..57 Fig 4.5 Bar graphs showing the proportion of Radical changes relative to the total number of changes in Gag gene…………………………………………………..…..……58 Fig 4.6 Bar graphs showing the proportion of Radical changes relative to the total number of changes in Pol gene…………………………………………………….………59 vi LIST OF TABLES Table 2.1 GenBank accession numbers of 67 B subtype sequences ………..…..24 Table 2.2 GenBank accession numbers of 135 CRF subtype sequences …….…26 Table 2.3 Distribution of different types of epitope regions in each gene and the number of codons in each epitope category for the 3 longest genes, Gag, Pol and Env…27 Table 2.4: Average nucleotide p-distance values for different epitope regions of Env, Gag and Pol genes from HIV-1 sequences of B-subtype and CRFs...….28 Table 2.5 Three types of amino acid classifications based on physicochemical properties (Modified from Zhang 2000)………………………..………….………………..29 Table 3.1 Average estimates of synonymous (d S) and nonsynonymous (d N) Nucleotide substitutions in different epitope regions of Env gene among B subtype and CRF sequences …………………………………………………………………………41 Table 3.2 Average estimates of synonymous (d S) and nonsynonymous (d N) Nucleotide substitutions in different epitope regions of Gag gene among B subtype and CRF sequences…………………………………………………………………….……42 Table 3.3 Average estimates of synonymous (d S) and nonsynonymous (d N) Nucleotide Substitutions in different epitope regions of Pol gene among B subtype and CRF sequences…………………………………………………………………….……42 Table 4.1 Number of Radical and Conservative amino acid substitutions at Env gene from pairwise comparisons of B and CRF sequences along with the number of No change sites………………………………………………………………….…….61 Table 4.2 Number of Radical and Conservative amino acid substitutions at Gag gene vii from pairwise comparisons of B and CRF sequences along with the number of No change sites ……………………………………………………………………………..…62 Table 4.3 Number of Radical and Conservative amino acid substitutions at Pol gene from pairwise comparisons of B and CRF sequences along with the number of No change sites …………………………………………………….…………….....…..63 Table 4.4 Number of Radical and Conservative amino acid substitutions at Env gene from Pairwise comparisons of B-subtype sequences estimated with CRF ancestral sequence ……………………………………………………………………..………64 Table 4.5 Number of Radical and Conservative amino acid substitutions at Gag gene from Pairwise comparisons of B-subtype sequences estimated with CRF ancestral sequence ………………………………………………………………………………65 Table 4.6 Number of Radical and Conservative amino acid substitutions at Pol gene from Pairwise comparisons of B-subtype sequences estimated with CRF ancestral sequence …………………………………………..…………………………………65 viii LIST OF ABBREVIATIONS Ab - Antibody (Neutralizing antibody) AIDS - Acquired Immunodeficiency Syndrome AOCE – All Overlapping Conformational Epitopes AOLE – All Overlapping Linear Epitopes CE – Conformational Epitope CRF- Circulating Recombinant Forms CTL – Cytotoxic T Lymphocytes HIV – Human Immunodeficiency virus MEGA - Molecular Evolutionary Genetics Analysis SIV – Simian Immunodeficiency Virus Th – T-Helper ix Acknowledgements It is a pleasure to thank the many people who made this thesis possible. It is difficult to overstate my gratitude to my Masters principle Advisor, Dr. Helen Piontkivska. With her enthusiasm, inspiration, and her great efforts to explain things clearly and simply, helped me to make the subject fun for me. Throughout my thesis- writing period, she provided encouragement, sound advice, good teaching, and lots of good ideas. I would have been lost without her. Besides my advisor, I would like to thank the rest of my thesis committee: Dr. Gail Fraizer and Dr. Michael Tubergen, for their encouragement and insightful comments. My sincere thanks to all my Professors who taught me in the Graduate school and also to all my teachers from India. I sincerely thank my labmate and friend, Sinu Paul for his support all through. I wish to thank the rest of my friends, Pawan Puri, Teja, Sourabh ,Sudhakar, Hari and many more for helping me get through the difficult times, and for all the support, entertainment, and caring they provided. Lastly, and most importantly, I wish
Recommended publications
  • Evaluation of T-Cell and B-Cell Epitopes and Design of Multivalent Vaccines Against Htlv-1 Diseases
    EVALUATION OF T-CELL AND B-CELL EPITOPES AND DESIGN OF MULTIVALENT VACCINES AGAINST HTLV-1 DISEASES DISSERTATION Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University By Roshni Sundaram, M.S. * * * * * The Ohio State University 2003 Dissertation Committee: Approved by Professor Pravin T.P. Kaumaya, Adviser Professor Christopher M. Walker Adviser Professor Neil R. Baker Department of Microbiology Professor Marshall V. Williams ABSTRACT Human T-cell lymphotropic virus type I (HTLV-1) is a C type retrovirus that is the causative agent of an aggressive T-cell malignancy, adult T-cell leukemia/lymphoma (ATLL). The virus is also implicated in a number of inflammatory disorders, the most prominent among them being HTLV-1 associated myelopathy or tropical spastic paraparesis (HAM/TSP). HTLV-1, like many viruses that cause chronic infection, has adapted to persist in the face of an active immune response in infected individuals. The viral transactivator Tax is the primary target of the cellular immune response and humoral responses are mainly directed against the envelope protein. Vaccination against HTLV-1 is a feasible option as there is very little genetic and antigenic variability. Vaccination regimes against chronic viruses must be aimed at augmenting the immune response to a level that is sufficient to clear the virus. This requires that the vaccine delivers a potent stimulus to the immune system that closely resembles natural infection to activate both the humoral arm and the cellular arm. It is also clear that multicomponent vaccines may be more beneficial in terms of increasing the breadth of the immune response as well as being applicable in an outbred population.
    [Show full text]
  • Mapping B-Cell Epitopes for Nonspecific Lipid Transfer Proteins of Legumes Consumed in India and Identification of Critical Resi
    foods Article Mapping B-Cell Epitopes for Nonspecific Lipid Transfer Proteins of Legumes Consumed in India and Identification of Critical Residues Responsible for IgE Binding Ankita Mishra 1,* and Ashok Kumar 1,2,3,4 1 Department of Biological Sciences and Bioengineering, Indian Institute of Technology Kanpur, Kanpur 208016, UP, India; [email protected] 2 Centre for Environmental Science and Engineering, Indian Institute of Technology Kanpur, Kanpur 208016, UP, India 3 Centre for Nanosciences, Indian Institute of Technology Kanpur, Kanpur 208016, UP, India 4 The Mehta Family Centre for Engineering in Medicine, Indian Institute of Technology Kanpur, Kanpur 208016, UP, India * Correspondence: [email protected] Abstract: Nonspecific lipid transfer proteins (nsLTPs) have been categorized as panallergens and display widespread occurrence across plant-kingdom. Present study, investigated B-cell epitopes for LTPs from chickpea, mung-bean, cowpea, pigeon-pea, and soybean via in silico methods. In-silico predicted regions were evaluated for epitope-conservancy and property-based peptide similarity search by different allergen databases. Additionally, the in-silico predicted regions were compared Citation: Mishra, A.; Kumar, A. with the experimentally validated epitopes of peach-LTP. Sequence-homology studies showed that Mapping B-Cell Epitopes for chickpea and mung-bean LTPs shared significant homology, i.e., >70% and >60%, respectively, with Nonspecific Lipid Transfer Proteins of other LTP allergens from lentil, garden-pea, peanut, etc. Phylogenetic-analysis also showed chickpea Legumes Consumed in India and and mung-bean LTPs to be closely related to allergenic LTPs from lentil and peanut, respectively. Identification of Critical Residues Responsible for IgE Binding. Foods Epitope-conservation analysis showed that two of the predicted B-cell epitopic regions in chickpea 2021, 10, 1269.
    [Show full text]
  • Opportunities for Conformation-Selective Antibodies in Amyloid-Related Diseases
    Antibodies 2015, 4, 170-196; doi:10.3390/antib4030170 OPEN ACCESS antibodies ISSN 2073-4468 www.mdpi.com/journal/antibodies Review Opportunities for Conformation-Selective Antibodies in Amyloid-Related Diseases Marta Westwood * and Alastair D. G. Lawson Structural Biology, UCB, 216 Bath Road, Slough, SL1 3WE UK; E-Mail: [email protected]. * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +44-1-753-534-655 (ext.7749); Fax: +44-1-753-536-632. Academic Editor: Dimiter S. Dimitrov Received: 13 May 2015 / Accepted: 9 July 2015 / Published: 15 July 2015 Abstract: Assembly of misfolded proteins into fibrillar deposits is a common feature of many neurodegenerative diseases. Developing effective therapies to these complex, and not yet fully understood diseases is currently one of the greatest medical challenges facing society. Slow and initially asymptomatic onset of neurodegenerative disorders requires profound understanding of the processes occurring at early stages of the disease including identification and structural characterisation of initial toxic species underlying neurodegeneration. In this review, we chart the latest progress made towards understanding the multifactorial process leading to amyloid formation and highlight efforts made in the development of therapeutic antibodies for the treatment of amyloid-based disorders. The specificity and selectivity of conformational antibodies make them attractive research probes to differentiate between transient states preceding formation of mature fibrils and enable strategies for potential therapeutic intervention to be considered. Keywords: antibody; amyloids; conformation; prion; Alzheimer’s; Parkinson’s; fibrils, tau; Huntingtin; protein misfolding 1. Introduction Correct protein folding is crucial for maintaining healthy biological functions.
    [Show full text]
  • Inhibition of Allergic Reactivity Through Targeting Fcεri-Bound Ige with Humanized Low-Affinity Antibodies
    Inhibition of Allergic Reactivity through Targeting Fc εRI-Bound IgE with Humanized Low-Affinity Antibodies This information is current as Ke Zhang, Michael Elias, Hong Zhang, Jeffrey Liu, of September 27, 2021. Christopher Kepley, Yun Bai, Dean D. Metcalfe, Zachary Schiller, Yang Wang and Andrew Saxon J Immunol published online 21 October 2019 http://www.jimmunol.org/content/early/2019/10/19/jimmun ol.1900112 Downloaded from Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on September 27, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2019 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Published October 21, 2019, doi:10.4049/jimmunol.1900112 The Journal of Immunology Inhibition of Allergic Reactivity through Targeting Fc«RI-Bound IgE with Humanized Low-Affinity Antibodies Ke Zhang,* Michael Elias,† Hong Zhang,* Jeffrey Liu,* Christopher Kepley,† Yun Bai,‡ Dean D. Metcalfe,‡ Zachary Schiller,x Yang Wang,x and Andrew Saxon* Options for effective prevention and treatment of epidemic allergic diseases remain limited, and particularly so for IgE-mediated 26 28 food allergies.
    [Show full text]
  • Ige – the Main Player of Food Allergy
    DDMOD-431; No of Pages 8 Vol. xxx, No. xx 2016 Drug Discovery Today: Disease Models Editors-in-Chief Jan Tornell – AstraZeneca, Sweden DRUG DISCOVERY Andrew McCulloch – University of California, SanDiego, USA TODAY DISEASE MODELS IgE – the main player of food allergy 1 2,3 2 Henrike C.H. Broekman , Thomas Eiwegger , Julia Upton , 4, Katrine L. Bøgh * 1 Department of Dermatology/Allergology, University Medical Centre Utrecht (UMCU), Utrecht, The Netherlands 2 Division of Immunology and Allergy, Food Allergy and Anaphylaxis Program, The Department of Paediatrics, Hospital for Sick Children, Toronto, Canada 3 Research Institute, Physiology and Experimental Medicine, The University of Toronto, Toronto, Canada 4 National Food Institute, Technical University of Denmark, Søborg, Denmark Food allergy is a growing problem worldwide, presently Section editor: affecting 2–4% of adults and 5–8% of young children. IgE Michelle Epstein – Medical University of Vienna, is a key player in food allergy. Consequently huge Department of Dermatology, DIAID, Experimental Allergy, Waehringer Guertel 18-20, Room 4P9.02, A1090, efforts have been made to develop tests to detect Vienna, Austria. either the presence of IgE molecules, their allergen binding sites or their functionality, in order to provide allergen ingestion [1], and involve one or more of the follow- information regarding the patient’s food allergy. The ing systems; the skin (pruritus, urticaria, or angioedema), the ultimate goal is to develop tools that are capable of gastro-intestinal tract (diarrhea, vomiting, contractions, in- creased bowel movement), the respiratory tract (asthma at- discriminating between asymptomatic sensitization tack, hoarseness, stridor/laryngeal angioedema) or the and a clinically relevant food allergy, and between cardiovascular system (dizziness, drop in blood pressure, loss different allergic phenotypes in an accurate and trust- of consciousness) [2,3].
    [Show full text]
  • Characterization of Conformational B-Cell
    PEPTIDE-BASED B-CELL EPITOPE VACCINES TARGETING HER-2/NEU DISSERTATION Presented in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy in the Graduate School of The Ohio State University By Joan T. Garrett, B.S./B.A. ***** The Ohio State University 2007 Dissertation Committee: Approved by Professor Pravin Kaumaya, Advisor ___________________________ Advisor Professor Dehua Pei, Advisor Professor Ross Dalbey ___________________________ Advisor Professor Thomas Magliery Graduate Program in Chemistry ABSTRACT HER-2/neu (ErbB2), a member of the epidermal growth factor family of receptors (EGFR) is overexpressed in a significant fraction of breast cancers. It is an attractive target for receptor-directed antitumor therapy using monoclonal antibodies. Trastuzumab and pertuzumab are growth-inhibitory humanized antibodies targeting the oncogenic protein HER-2/neu. Although passive immunotherapy with trastuzumab is approved for treatment of breast cancer, a number of concerns exist with passive immunotherapy. Treatment is expensive, and has a limited duration of action, necessitating repeated administrations of the monoclonal antibody. Active immunotherapy with conformational B-cell epitopes affords the possibility of generating an enduring immune response, eliciting protein-reactive high-affinity anti-peptide antibodies. The three-dimensional structure of human HER-2 in complex with trastuzumab reveals that the antigen binding region of HER-2 spans residues 563-626 that comprises an extensive disulfide bonding pattern. In order to minimally dissect the interacting binding region of HER-2, we have designed four synthetic peptides with different levels of conformational flexibility. Chimeric peptides incorporating the measles virus fusion ‘promiscuous’ T cell epitope via a four-residue linker sequence were synthesized, purified, and characterized.
    [Show full text]
  • HDX-MS for Epitope Characterization of a Therapeutic ANTIBODY Candidate on the Calcium-Binding Protein Annexin-A1
    antibodies Article HDX-MS for Epitope Characterization of a Therapeutic ANTIBODY Candidate on the Calcium-Binding Protein Annexin-A1 Marius Gramlich 1, Henry C. W. Hays 2, Scott Crichton 2, Philipp D. Kaiser 1, Anne Heine 1, Nicole Schneiderhan-Marra 1, Ulrich Rothbauer 1,3, Dieter Stoll 1,4, Sandra Maier 1 and Anne Zeck 1,* 1 NMI, Natural and Medical Sciences Institute at the University of Tuebingen, Markwiesenstr. 55, 72770 Reutlingen, Germany; [email protected] (M.G.); [email protected] (P.D.K.); [email protected] (A.H.); [email protected] (N.S.-M.); [email protected] (U.R.); [email protected] (D.S.); [email protected] (S.M.) 2 Medannex Ltd., 1 Lochrin Square, Fountainbridge, Edinburgh EH3 9QA, UK; [email protected] (H.C.W.H.); [email protected] (S.C.) 3 Pharmaceutical Biotechnology, Eberhard Karls University Tuebingen, Geschwister-Scholl-Platz, 72074 Tuebingen, Germany 4 Department of Life Sciences, University of Applied Sciences Albstadt-Sigmaringen, Anton-Guentherstr. 51, 72488 Sigmaringen, Germany * Correspondence: [email protected]; Tel.: +49-7121-51530-0; Fax: +49-7121-51530-816 Abstract: Annexin-A1 (ANXA1) belongs to a class of highly homologous Ca2+-dependent phospholipid- binding proteins. Its structure consists of a core region composed of four homologous repeats ar- ranged in a compact, hydrolysis-resistant structure and an N-terminal region with a Ca2+-dependent conformation. ANXA1 is involved in several processes, including cell proliferation, apoptosis, Citation: Gramlich, M.; Hays, metastasis, and the inflammatory response. Therefore, the development of antibodies blocking H.C.W.; Crichton, S.; Kaiser, P.D.; selected regions on ANXA1 holds great potential for the development of novel therapeutics treating Heine, A.; Schneiderhan-Marra, N.; inflammatory and cancer diseases.
    [Show full text]
  • Epitope Recognition in HLA-DR3 Transgenic Mice Immunized to TSH-R Protein Or Peptides Hidefumi Inaba
    University of Rhode Island DigitalCommons@URI Institute for Immunology and Informatics Faculty Institute for Immunology and Informatics (iCubed) Publications 2013 Epitope Recognition in HLA-DR3 Transgenic Mice Immunized to TSH-R Protein or Peptides Hidefumi Inaba Leonard Moise University of Rhode Island See next page for additional authors Follow this and additional works at: https://digitalcommons.uri.edu/immunology_facpubs The University of Rhode Island Faculty have made this article openly available. Please let us know how Open Access to this research benefits oy u. This is a pre-publication author manuscript of the final, published article. Terms of Use This article is made available under the terms and conditions applicable towards Open Access Policy Articles, as set forth in our Terms of Use. Citation/Publisher Attribution Inaba, H., Moise, L., Martin, W., De Groot, A. S., Desrosiers, J., Tassone, R., Buchman, G., Akamizu, T., & De Groot, L. J. (2013). Epitope Recognition in HLA-DR3 Transgenic Mice Immunized to TSH-R Protein or Peptides. Endocrinology, 154(6), 2234-2243. Available at: http://dx.doi.org/10.1210/en.2013-1033 This Article is brought to you for free and open access by the Institute for Immunology and Informatics (iCubed) at DigitalCommons@URI. It has been accepted for inclusion in Institute for Immunology and Informatics Faculty Publications by an authorized administrator of DigitalCommons@URI. For more information, please contact [email protected]. Authors Hidefumi Inaba, Leonard Moise, William Martin, Anne S. De Groot, Joe Desrosiers, Ryan Tassone, George Buchman, Takashi Akamizu, and Leslie J. De Groot This article is available at DigitalCommons@URI: https://digitalcommons.uri.edu/immunology_facpubs/68 1 Title 2 EPITOPE RECOGNITION IN HLA-DR3 TRANSGENIC MICE IMMUNIZED TO TSH-R 3 PROTEIN OR PEPTIDES 4 5 Hidefumi Inaba, Leonard Moise, William Martin, Anne S.earls De Groot, 6 Joe Desrosiers, Ryan Tassone, George Buchman, Takashi Akamizu, 7 and Leslie J.
    [Show full text]
  • Recognition Stereotyped Repertoire of Epitope Bind the Same Linear Peptide
    Two Human Neonatal IgM Antibodies Encoded by Different Variable-Region Genes Bind the Same Linear Peptide: Evidence for a Stereotyped Repertoire of Epitope Recognition1 Bradley T. Messmer,* James J. Sullivan,* Nicholas Chiorazzi,† Toby C. Rodman,* and David S. Thaler2* Two monoclonal IgM Abs have been produced from lymphocytes isolated from two human umbilical cord bloods. These mAbs recognize a conformational epitope present in a CNBr digestion fraction of lactoferrin. Linear epitopes recognized by each mAb were selected from several phage display peptide libraries. In each case, phages displaying a peptide with a motif defined by [WF],G,[EQS],N were recovered. Phages displaying that motif bound equally well to either mAb but did not bind to control IgM. A peptide bearing this motif competed with the phage-displayed peptides for binding to either mAb. The same peptide also competes with a component of the CNBr digestion fraction of lactoferrin for Ab binding in ELISA. The Abs use different families of VH,JH, and VK gene cassettes but use the same JK cassette. All segments are virtually identical to their germline gene counterparts. This work provides further evidence that certain innate specificities are stereotyped among individuals. The Jour- nal of Immunology, 1999, 162: 2184–2192. uman serum contains Abs that have not arisen as a result Several lines of evidence support the possibility that the natu- of direct immunization with foreign Ag or pathogenic rally occurring Ab repertoire in human neonates contains certain H exposure (1). These Abs have been called “natural” (2) stereotyped specificities. Homogenous tissue extracts separated on or “innate” (3).
    [Show full text]
  • Structure of a Protective Epitope of Group B Streptococcus Type III Capsular Polysaccharide
    Structure of a protective epitope of group B Streptococcus type III capsular polysaccharide Filippo Carbonia, Roberto Adamoa,1, Monica Fabbrinia, Riccardo De Riccoa, Vittorio Cattaneoa, Barbara Brogionia, Daniele Veggia, Vittoria Pintoa, Irene Passalacquaa, Davide Oldrinia, Rino Rappuolia,2, Enrico Malitoa, Immaculada y Ros Margarita,1, and Francesco Bertia,1,2 aGSK Vaccines, 53100 Siena, Italy Contributed by Rino Rappuoli, March 27, 2017 (sent for review February 3, 2017; reviewed by Dennis L. Kasper and Robert J. Woods) Despite substantial progress in the prevention of group B Strepto- GBS is an encapsulated Gram-positive β-hemolytic pathogen coccus (GBS) disease with the introduction of intrapartum antibiotic causing neonatal sepsis and meningitis, particularly in infants born prophylaxis, this pathogen remains a leading cause of neonatal to mothers carrying the bacteria (12). The GBS capsular PS is infection. Capsular polysaccharide conjugate vaccines have been constituted by multiple RUs (from ∼50 up to 300 per polymer) of tested in phase I/II clinical studies, showing promise for further de- four to seven monosaccharides shaped to form a backbone and one velopment. Mapping of epitopes recognized by protective anti- or two side chains. Ten serotypes presenting a unique pattern of bodies is crucial for understanding the mechanism of action of glycosidic linkages have been identified and their primary struc- vaccines and for enabling antigen design. In this study, we report β the structure of the epitope recognized by a monoclonal antibody tures elucidated (13). Three monosaccharides ( -D-glucopyranose, β β β β with opsonophagocytic activity and representative of the protective -D-Glc; -D-galactopyranose, -D-Gal; and -D-N-acetylglucosamine, response against type III GBS polysaccharide.
    [Show full text]
  • Proinflammatory Action of a New Electronegative Low-Density Lipoprotein Epitope
    biomolecules Article Proinflammatory Action of a New Electronegative Low-Density Lipoprotein Epitope 1, 1, 1 Tanize do Espirito Santo Faulin y, Soraya Megumi Kazuma y, Gustavo Luis Tripodi , Marcela Frota Cavalcante 1, Felipe Wakasuqui 1, Cristiano Luis Pinto Oliveira 2, Maximilia Frazão de Souza Degenhardt 2, Jussara Michaloski 3, Ricardo José Giordano 3 , Daniel Francisco Jacon Ketelhuth 4,5 and Dulcineia Saes Parra Abdalla 1,* 1 Department of Clinical and Toxicological Analyses, Faculty of Pharmaceutical Sciences, University of Sao Paulo, Sao Paulo 05508-000, Brazil 2 Department of Experimental Physics, Institute of Physics, University of Sao Paulo, Sao Paulo 05508-090, Brazil 3 Department of Biochemistry, Institute of Chemistry, University of Sao Paulo, Sao Paulo 05508-000, SP, Brazil 4 Centre for Molecular Medicine, Department of Medicine, Karolinska University Hospital, Karolinska Institute, 17164 Stockholm, Sweden 5 Department of Cardiovascular and Renal Research, Institute for Molecular Medicine, University of Southern Denmark (SDU), 5000 Odense, Denmark * Correspondence: [email protected]; Tel.: +55-11-3091-3637 These authors contributed equally to this work. y Received: 13 July 2019; Accepted: 13 August 2019; Published: 20 August 2019 Abstract: The electronegative low-density lipoprotein, LDL ( ), is an endogenously modified − LDL subfraction with cytotoxic and proinflammatory actions on endothelial cells, monocytes, and macrophages contributing to the progression of atherosclerosis. In this study, epitopes of LDL ( ) were mapped using a phage display library of peptides and monoclonal antibodies reactive − to this modified lipoprotein. Two different peptide libraries (X6 and CX8C for 6- and 8-amino acid-long peptides, respectively) were used in the mapping. Among all tested peptides, two circular peptides, P1A3 and P2C7, were selected based on their high affinities for the monoclonal antibodies.
    [Show full text]
  • A Single Conformational Transglutaminase 2 Epitope Contributed by Three Domains Is Critical for Celiac Antibody Binding and Effects
    A single conformational transglutaminase 2 epitope contributed by three domains is critical for celiac antibody binding and effects Zsófia Simon-Vecseia, Róbert Királya,b, Péter Bagossia, Boglárka Tótha, Ingrid Dahlbomc, Sergio Cajad, Éva Csősza, Katri Lindforsd, Daniele Sblatteroe, Éva Nemesf, Markku Mäkid, László Fésüsa,b, and Ilma R. Korponay-Szabóf,g,1 aDepartment of Biochemistry and Molecular Biology, Medical and Health Science Center, University of Debrecen, Nagyerdei krt 98, Debrecen H-4032, Hungary; bApoptosis and Genomics Research Group of Hungarian Academy of Sciences, Debrecen H-4032, Hungary; cDepartment of Women’s and Children’s Health, University of Uppsala, Uppsala SE-75185, Sweden; dPaediatric Research Centre, University of Tampere and Tampere University Hospital, Tampere, FIN-33014, Finland; eDepartment of Medical Sciences and Interdisciplinary Research Center of Autoimmune Disease (IRCAD), University of Eastern Piedmont, Novara 28100, Italy; fDepartment of Pediatrics, Medical and Health Science Center, University of Debrecen, Debrecen H-4032, Hungary; and gCeliac Disease Center, Heim Pál Children’s Hospital, Budapest H-1089, Hungary Edited by Michael Sela, Weizmann Institute of Science, Rehovot, Israel, and approved October 31, 2011 (received for review June 18, 2011) The multifunctional, protein cross-linking transglutaminase 2 (TG2) testinal inflammation, and villous atrophy in genetic susceptible is the main autoantigen in celiac disease, an autoimmune disorder individuals carrying HLA-DQ2 or DQ8 (4). with defined etiology. Glutamine-rich gliadin peptides from in- Celiac antibodies exert biological effects via TG2, partly by gested cereals, after their deamidation by TG2, induce T-lympho- gain in catalytic activity, on epithelial cell differentiation (5) and cyte activation accompanied by autoantibody production against transport (6), angiogenesis (7), vascular permeability (8), mono- TG2 in 1–2% of the population.
    [Show full text]